Bharat Parenterals [BPLPHARMA] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Bharat Parenterals Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bharat Parenterals Ltd. wins in 6 metrics, Divi's Laboratories Ltd. wins in 13 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bharat Parenterals Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) -18.20 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 1.90 10.82 Bharat Parenterals Ltd.
Debt-to-Equity Ratio 39.74 0.58 Divi's Laboratories Ltd.
PEG Ratio -0.45 4.63 Divi's Laboratories Ltd.
EV/EBITDA 11.90 48.63 Bharat Parenterals Ltd.
Profit Margin (TTM) -2.32% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) -10.30% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) N/A 29.65% N/A
Return on Equity -3.72% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) -1.95% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-563.30M $2.15B Divi's Laboratories Ltd.
Dividend Yield 0.08% 0.91% Divi's Laboratories Ltd.
1-Year Return 10.27% 0.83% Bharat Parenterals Ltd.
Price-to-Sales Ratio (TTM) 2.39 16.18 Bharat Parenterals Ltd.
Enterprise Value $4.88B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.39 15.86 Bharat Parenterals Ltd.
Gross Profit Margin (TTM) 50.44% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $553 $388 Bharat Parenterals Ltd.
Earnings per Share (Diluted) $-42.80 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.57 0.19 Divi's Laboratories Ltd.

Bharat Parenterals Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

BPLPHARMA
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bharat Parenterals Ltd.7.15%7.11%11.16%24.46%18.70%15.70%
Divi's Laboratories Ltd.0.67%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bharat Parenterals Ltd.10.27%274.77%198.94%895.74%895.74%895.74%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Bharat Parenterals Ltd. vs Divi's Laboratories Ltd.

MetricBPLPHARMADIVISLAB
Market Information
Market Cap i₹8.36B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,929253,443
90 Day Avg. Volume i2,703283,911
Last Close₹1,400.00₹6,576.50
52 Week Range₹880.25 - ₹1,667.20₹5,636.50 - ₹7,071.50
% from 52W High-16.03%-7.00%
All-Time High₹1,870.00 (Dec 02, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-25.13%-7.00%
Growth Metrics
Quarterly Revenue Growth-0.10%0.12%
Quarterly Earnings Growth-0.10%-0.01%
Financial Health
Profit Margin (TTM) i-0.02%0.24%
Operating Margin (TTM) i-0.10%0.30%
Return on Equity (TTM) i-0.04%0.15%
Debt to Equity (MRQ) i39.740.58
Cash & Liquidity
Book Value per Share (MRQ)₹640.06₹580.95
Cash per Share (MRQ)₹64.78₹122.95
Operating Cash Flow (TTM) i₹-654,312,000₹19.67B
Levered Free Cash Flow (TTM) i₹-126,262,000₹21.91B
Dividends
Last 12-Month Dividend Yield i0.08%0.91%
Last 12-Month Dividend i₹1.00₹60.00

Valuation & Enterprise Metrics Analysis: Bharat Parenterals Ltd. vs Divi's Laboratories Ltd.

MetricBPLPHARMA (Apr 22, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-18.2067.11
Forward P/E iN/A53.75
PEG Ratio i-0.454.63
Price to Sales (TTM) i2.3916.18
Price to Book (MRQ) i1.9010.82
Market Capitalization
Market Capitalization i₹8.36B₹1.69T
Enterprise Value i₹4.88B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.3915.86
Enterprise to EBITDA i11.9048.63
Risk & Other Metrics
Beta i0.570.19
Book Value per Share (MRQ) i₹640.06₹580.95

Financial Statements Comparison: Bharat Parenterals Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBPLPHARMA (2025)DIVISLAB (2025)
Revenue/Sales i3.35B93.25B
Cost of Goods Sold i2.12B38.70B
COGS % of Revenue i63.1%41.5%
Gross Profit i1.24B54.55B
Gross Margin i36.9%58.5%
Research & Development i65.14M270.00M
Operating Income (EBIT) i-308.90M25.71B
Operating Margin i-9.2%27.6%
EBITDA i142.48M33.19B
EBITDA Margin i4.2%35.6%
Pre-Tax Income i-339.51M29.16B
Pre-Tax Income % of Revenue i-10.1%31.3%
Income Tax i97.25M7.25B
Income Tax % of Revenue i2.9%7.8%
Net Income (Profit) i-436.75M21.91B
Profit Margin i-13.0%23.5%

Balance Sheet & Liquidity Metrics

MetricBPLPHARMA (2025)DIVISLAB (2025)
Cash & Equivalents i5.60M4.15B
Total Current Assets i3.56B100.81B
Total Current Assets % of Revenue i106.0%108.1%
Total Current Liabilities i2.19B14.52B
Total Current Liabilities % of Revenue i65.4%15.6%
Long-Term Debt i758.67M20.00M
Long-Term Debt % of Revenue i22.6%0.0%
Total Shareholders Equity i3.39B149.69B
Retained Earnings i1.75B134.00B
Retained Earnings % of Revenue i52.1%143.7%
Property, Plant & Equipment i60.23M3.19B

Cash Flow Statement Comparison

MetricBPLPHARMA (2025)DIVISLAB (2025)
Operating Cash Flow i-654.31M19.67B
Operating Cash Flow % of Revenue i-19.5%21.1%
Capital Expenditures i-286.21M-14.38B
Free Cash Flow i-563.30M2.15B
FCF Margin i-16.8%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBPLPHARMADIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.89M265.47M
Float Shares i658,947117.72M
% Held by Insiders i79.74%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i20.26%19.31%

Dividend Analysis & Yield Comparison: Bharat Parenterals Ltd. vs Divi's Laboratories Ltd.

MetricBPLPHARMADIVISLAB
Last 12-Month Dividend i₹1.00₹60.00
Last 12-Month Dividend Yield i0.08%0.91%
3-Year Avg Annual Dividend i₹0.33₹50.00
3-Year Avg Dividend Yield i0.08%0.70%
3-Year Total Dividends i₹1.00₹150.00
Ex-Dividend DateSep 19, 2025Jul 25, 2025